Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Announcing the new Tapestri Solution for Solid Tumor Oncology Research. Learn More
X
Scientific presentation

Resolving tumor heterogeneity with single-cell co-detection of SNVs, CNVs, and immunophenotypes


Aaron Llanso
Description

Single-cell sequencing methods have enabled multi-modal characterization of tumor heterogeneity and yielded novel insights into tumor evolution, therapeutic response and resistance, and measurable residual disease (MRD). Aaron Llanson, DIrector of Market Development at Mission Bio, gives an overview of the Tapestri Platform and showcases the novel capability to co-detect SNVs, indels, CNVs, and immunophenotypes from the same cell with a single, high-throughput workflow. Single-cell multi-modal sequencing unlocks the ability to truly understand clonal architecture and resolve tumor heterogeneity.



VIEW


Scientific presentation
Single cell Genotypic and Immunotypic Analysis of Measurable Residual Disease in Acute Myeloid Leukemia
Ross Levine, MD
Tapestri scMRD for AML Summit (2022)
Scientific presentation
Bioinformatics approach to demultiplexing scMRD
Troy Robinson, MSKCC
Tapestri scMRD for AML Summit (2022)
Scientific presentation
Opportunities for Single-cell Multi-omics in the Clinic: MRD and Beyond
Ross Levine
Marina Konopleva
Saar Gill
Wenbin Xiao
Mikhail Roshal
Tapestri scMRD for AML Summit (2022)
Scientific presentation
Single-cell Multi-omics and the Horizon of Clinical Utility
Aaron Llanso
(2022)
REQUEST QUOTE